ResMed Inc.
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operat...
Latest News
8 hours ago · fool.com
ResMed: 3 Key Takeaways for Long-Term InvestorsResMed reported that core constant currency revenue grew 7% in the first quarter. Patients on GLP-1 drugs are 11% more likely to start CPAP therapy.
3 days ago · zacks.com
ResMed (RMD) Reports Q1 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for ResMed (RMD) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
3 days ago · zacks.com
RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin ClimbsResMed's first-quarter fiscal 2027 earnings and revenues top estimates as sustained sleep device demand, productivity gains and gross margin expansion drive growth.
3 days ago · marketbeat.com
What ResMed (RMD) Said on Its Q1 Earnings CallResMed NYSE: RMD reported first-quarter fiscal 2027 revenue of $1.4 billion, up 6% from a year earlier on a reported basis and 7% on a core constant-currency basis, as growth in sleep devices, masks and residential care software offset declines in life-support device sales. Non-GAAP diluted earnings per share rose 14% to $2.91.
3 days ago · seekingalpha.com
ResMed Inc. (RMD) Q1 2027 Earnings Call TranscriptResMed Inc. (RMD) Q1 2027 Earnings Call Transcript
3 days ago · zacks.com
ResMed (RMD) Beats Q1 Earnings and Revenue EstimatesResMed (RMD) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.67 per share. This compares to earnings of $2.55 per share a year ago.
3 days ago · benzinga.com
ResMed Q1 2027 Earnings Call TranscriptResMed (NYSE:RMD) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below.
3 days ago · globenewswire.com
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
5 days ago · zacks.com
Unlocking Q1 Potential of ResMed (RMD): Exploring Wall Street Estimates for Key MetricsLooking beyond Wall Street's top-and-bottom-line estimate forecasts for ResMed (RMD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
10 days ago · zacks.com
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove RMD